UK medical device company Creavo Medical Technologies has appointed Jaspal Singh as its new European Director of Sales, in preparation for the next phase of growth and the EMEA commercialisation of Corsens® , its portable magnetocardiography (MCG) device.
Jaspal brings over 15 years’ sales experience in the medical device industry. He joins from Fresenius Medical Care, where he worked as the UK Business Unit Manager within the renal sector. Prior to this, Jaspal held various senior sales roles with medical device company, Stryker UK.
He will be responsible for building a direct sales operation and has ambitions to grow the commercial team across the UK and EU by 2020, in order to support distribution partners in key EMEA markets. Jaspal will develop the company sales strategy and execute it in a prioritised subset of countries to deliver key goals for the business.
Steve Parker, CEO of Creavo, said: “Jaspal is highly regarded with significant international experience, industry knowledge and commercial expertise. We are delighted to welcome him to our senior management team - his input will be vital as we move into our next phase of growth.”
Commenting on his appointment, Jaspal said: “I am truly excited to be joining a company which, at its heart, is truly innovative and progressive. The company has a strong value proposition and I wanted to be part of the ambition to revolutionise the healthcare market. I’m very much looking forward to working with the remarkable team at Creavo.”
Creavo will manage UK market supply for Corsens® directly and has secured distribution partners for Europe and the Middle East, with additional territories planned as part of an ongoing programme.
Corsens® has the potential to help physicians accurately and quickly rule out acute coronary syndromes with a simple, non-invasive scan within minutes at a patient’s bedside. Identifying at-risk patients early potentially reduces patient anxiety and saves the healthcare system valuable time, resources and bed space.